Ulrich Ronellenfitsch

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk et al. · The Lancet Oncology · 2016 · 739 citations

Medicine, Oncology, Pharmacology +16

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk et al. · JAMA Oncology · 2017 · 474 citations · Full text

Medicine, Oncology, Surgery +15

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 289 citations · Full text

Medicine, Oncology, Surgery +11

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

James Glasbey, Dmitri Nepogodiev, Joana Simões et al. · Journal of Clinical Oncology · 2020 · 222 citations · Full text

Medicine, Oncology, Surgery +11

Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour

Peter Hohenberger, Ulrich Ronellenfitsch, Oluwole Solomon Oladeji et al. · British journal of surgery · 2010 · 211 citations · Full text

Medicine, Oncology, Surgery +13